Drug
Sar443216
Sar443216: highest development phase Phase 1, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| SAR443216 IV NCT05013554 | Phase 1 | Neoplasm Malignant |
Latest
No recent events.
Follow Sar443216 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.